Recently, advances in the understanding of the pathogenesis of multiple sclerosis, particularly the crosstalk between B and T cells, has led to a change in therapeutic approach, with an emphasis on the use of highly active approaches earlier in the disease process. Clinicians, armed with an understanding of the differential effects of highly active regimens, including immune-reconstitution therapies (IRTs) vs maintenance therapies, can make more educated risk:benefit assessments to inform optimal strategies for initial and sequential therapy for patients with relapsing/remitting MS. As new therapies become available, this conceptual schema must expand and incorporate the newer options. While knowledge and facility in this new approach is important for neurologists, other members of the care team, including advanced practice providers, neurology nurses, pharmacists, and patients must be informed and educated in order to address the realities of shared decision making, monitoring for and management of adverse effects, drug-drug interactions, and adherence to therapy.
To address these challenges, this initiative, The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles in MS, will review the immunology of MS and its application in therapeutic selection. Using case examples, the faculty will address the disease, drug, and patient factors affecting the choice of initial and sequential therapies. Triple accredited for physicians, nurses, and pharmacists, this activity will appeal to the entire range of clinicians who care for MS patients. Downloadable patient education materials related to this new approach are also included.
Release Date: 2/20/2020
Expiration Date: 2/19/2021
Estimated Time to Complete the Activity: 2 hrs
Media: Interactive, text-based activity
This activity has been designed to meet the educational needs of physicians, pharmacists, nursing professionals and other members of the healthcare team involved in the management of patients with MS.
Upon completing this activity, participants should be better able to:
Bruce A. Cohen, MD
Professor of Neurology (MS/Neuroimmunology)
Ken and Ruth Davee Department of Neurology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Jacquelyn (Jacci) Bainbridge, BS Pharm, PharmD, FCCP, MSCS
Professor, Department of Clinical Pharmacy
University of Colorado
Anschutz Medical Campus
Skaggs School of Pharmacy, Department of Clinical Pharmacy and Neurology
Aurora, Colorado
Amy Perrin Ross, RN, MSN, CNRN, MSCN
Neuroscience Program Coordinator
Loyola University Medical Center
Maywood, Illinois
In support of improving patient care, this activity has been planned and implemented by the Consortium of Multiple Sclerosis Centers (CMSC) and Terranova Medica LLC. CMSC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
The Consortium of Multiple Sclerosis Centers designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The Consortium of Multiple Sclerosis Centers designates this activity for 2.0 contact hours of continuing education (2.0 in the area of pharmacology) for nurses.
Pharmacists
The Consortium of Multiple Sclerosis Centers (CMSC) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education and will award 0.2 contact hours (0.2 CEUs) to pharmacists who (1) complete the activity, (2) submit a passing posttest, and (3) complete the evaluation form. The Universal Activity Number (UAN) for this activity is JA4008165-9999-20-003-H01-P. This is a knowledge-based activity.
Upon successful completion of the activity, your CE credits will be submitted electronically to the NABP CPE Monitor service. For information about CPE Monitor, visit https://nabp.pharmacy/cpe-monitor-service/
Certificate of Attendance for Other Healthcare Professionals
A Certificate of Attendance will be given upon completion of course requirements enabling participants to register their credit with the appropriate licensing boards or associations. Participants may apply for other accreditations using procedures established by specific organizations.
In accordance with the ACCME Standards for Commercial Support, CMSC and Terranova Medica LLC require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. CMSC and Terranova Medica LLC resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, CMSC and Terranova Medica LLC seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. CMSC and Terranova Medica LLC are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.
The program faculty reported the following relevant financial relationships that they have with commercial interests:
Bruce A. Cohen, MD, has disclosed the following relevant financial relationships:
Consulting fees: Biogen, EMD Serono, Genentech, Mylan
Contracted Research Support: Genentech/Roche, MedDay
Jacquelyn Bainbridge, BS Pharm, PharmD, FCCP, MSCS, has disclosed the following relevant financial relationships:
Advisory Board: Genentech
Amy Perrin Ross, RN, MSN, CNRN, MSCN, has disclosed the following relevant financial relationships:
Consulting fees: Biogen, EMD Serono, TEVA, Genzyme, Genentech, Alexion, Celgene, Novartis
Speakers Bureau: Biogen, EMD Serono, TEVA, Genzyme, Genentech, Alexion, Novartis
The planners, reviewers, editors, staff, or other members at CMSC who are in a position to control content have declared that they have no relevant financial relationships.
The planners, reviewers, editors, staff, or other members at Terranova Medica LLC who are in a position to control content have declared that they have no relevant financial relationships.
Internet
To successfully complete this activity, the participant must
CMSC and Terranova Medica LLC require faculty to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
This activity is supported by an educational grant received from EMD Serono.
CMSC and Terranova Medica LLC present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. CMSC, Terranova Medica LLC, and the commercial supporters assume no liability for the information herein.
Terranova Medica LLC and CMSC are committed to protecting the privacy of those who choose to participate in activities on artofmstherapy.org. This information below describes our security policies for safeguarding personal information as well as the rationale for collection and use of personal information.
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
Collection and use of personal information
Terranova Medica LLC and CMSC do not transfer, sell, or share personal information with outside parties. We will not disclose the information unless required in a legal proceeding.
If you have any questions about this activity, please contact Tom Davis of Terranova Medica LLC by telephone/fax (877-276-4523) or email (tdavis@terranovamedica.com).
